• Ferroelectric-Liquid Metal Photoreceptors Enable Biomimetic

  2026-06-29

  This study reports a hybrid ferroelectric-liquid metal photoreceptor that mimics human visual adaptation mechanisms and restores light perception in rodent models of retinal degeneration. The work demonstrates robust, biocompatible photoelectric conversion across visible and near-infrared wavelengths, suggesting a new direction for retinal prosthesis design.

• ω-Agatoxin IVA TFA: Redefining Cav2.1 Blockade in Translatio

  2026-06-29

  This thought-leadership article explores the mechanistic, experimental, and strategic landscape of ω-Agatoxin IVA TFA as a Cav2.1 channel inhibitor. Going beyond standard product descriptions, it synthesizes current evidence, protocol insights, and translational implications for researchers seeking reliable tools in neuroprotection and synaptic transmission research. The discussion integrates primary literature, reference product data, and competitive perspectives to guide informed experimental design and future innovation.

• Eicosapentaenoic Acid: Protocols and Innovations in Cardiova

  2026-06-28

  Eicosapentaenoic Acid (EPA) stands out as a rigorously characterized omega-3 fatty acid, enabling reproducible and advanced cardiovascular and immunomodulation studies. This article unpacks workflow optimizations, protocol enhancements, and troubleshooting strategies, clarifying EPA’s applied advantages and cross-domain potential.

• Acetylspiramycin Workflows: Advancing Antimicrobial Resistan

  2026-06-27

  Acetylspiramycin (Spiramycin B) enables precise benchmarking of macrolide efficacy in resistant Mycoplasma pneumoniae and Gram-positive models. Its dual action as a ribosomal inhibitor and immune modulator positions it as an essential tool for next-generation host-pathogen interaction studies.

• CHK1 Inhibition in Breast Cancer: ER/PR Status-Dependent Eff

  2026-06-26

  This study elucidates how the effectiveness of CHK1 inhibition in breast cancer is modulated by estrogen and progesterone receptor status, with distinct mechanisms underlying chemosensitization and single-agent activity. These insights provide a framework for more precise application of molecular targeted therapies in context of tumor heterogeneity.

• Protease Inhibitor Cocktail: Precision Safeguard for Protein

  2026-06-26

  Unlock robust protein extraction and phosphorylation studies with the Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO). Its unique EDTA-free composition ensures compatibility with cation-sensitive assays while delivering broad-spectrum protection against proteolysis, especially in workflows targeting post-translational modifications.

• Adipose-Neural Axis Drives Arrhythmia via Leptin-NPY Pathway

  2026-06-25

  Fan et al. (2024) demonstrate that the interplay between epicardial adipose tissue and the sympathetic nervous system, mediated by the leptin–NPY–Y1R axis, is a key driver of cardiac arrhythmias. Their innovative human stem cell-based coculture model provides new molecular targets and an advanced experimental platform for mechanistic arrhythmia research.

• Lypressin Acetate: Bridging Antidiuretic and Antiviral Innov

  2026-06-25

  Explore how Lypressin acetate advances both antidiuretic research and antiviral assay development. This article delivers a unique, mechanistic perspective on lysine vasopressin acetate, with actionable protocols and cross-domain insights.

• Dacarbazine: Applied Workflows and Troubleshooting in Oncolo

  2026-06-24

  Dacarbazine is a cornerstone antineoplastic chemotherapy drug for malignant melanoma, Hodgkin lymphoma, and sarcoma models. This guide delivers actionable protocols, troubleshooting strategies, and evidence-driven workflow enhancements—empowering cancer researchers to maximize experimental reproducibility and interpret DNA damage assays with confidence.

• Staurosporine in Metastasis Modeling: Unveiling Apoptosis-Dr

  2026-06-23

  Explore how Staurosporine, a broad-spectrum serine/threonine protein kinase inhibitor, uniquely enables advanced modeling of apoptosis-induced metastasis in cancer research. This article reveals mechanistic links between kinase inhibition, cell death, and pro-metastatic state induction—extending beyond standard apoptosis assays.

• Nanoparticle-Mediated mRNA Reverses Trastuzumab Resistance i

  2026-06-23

  This study introduces a tumor microenvironment-responsive nanoparticle system for systemic delivery of PTEN mRNA, targeting the PI3K/Akt pathway to overcome trastuzumab resistance in HER2-positive breast cancer. The findings highlight a promising approach for restoring tumor suppressor function and improving monoclonal antibody therapy outcomes.

• Nanoparticle-Mediated PTEN mRNA Delivery Reverses Trastuzuma

  2026-06-22

  This study demonstrates that tumor microenvironment-responsive nanoparticles can systemically deliver PTEN mRNA to overcome trastuzumab resistance in HER2-positive breast cancer. By restoring PTEN and inhibiting PI3K/Akt signaling, the approach offers a promising precision strategy for resistant cancer phenotypes.

• Ribonuclease R (20 U/μL): Streamlining Circular RNA Enrichme

  2026-06-22

  Ribonuclease R (RNase R) (20 U/μL) from APExBIO transforms circular RNA research by delivering highly selective linear RNA digestion, critical for advanced RNA structure-function and inflammation studies. Explore optimized workflows, troubleshooting strategies, and the translational impact of RNase R in dissecting complex RNA-mediated pathways.

• Synthetic Modified mRNA Enables Rapid hiPSC-to-Oligodendrocy

  2026-06-21

  The referenced study demonstrates a non-viral, synthetic modified mRNA (smRNA) approach for efficiently differentiating human-induced pluripotent stem cells (hiPSCs) into functional oligodendrocytes. By using OLIG2 S147A smRNA, the protocol achieves high-purity oligodendrocyte progenitor cells in six days, offering a safer and faster alternative to traditional methods for cell therapy and disease modeling.

• DFCP1 Modulates Starvation-Driven Lipid Droplet Lipolysis vi

  2026-06-20

  The reference study identifies DFCP1 as a nutrient-sensitive regulator of lipid droplet metabolism, acting through direct modulation of ATGL-mediated lipolysis during starvation. These insights clarify key molecular mechanisms in lipid mobilization and have implications for metabolic disease research and advanced protein stability workflows.

11463 records 1/765 page Next 12345 下5页 Last page